This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One of the essential parts of exponential growth in the healthcare emporium is effective marketing strategies. Furthermore, with the increment in the need for hospital beds, healthcare systems are in dire need of such approaches. Like any industry, a relevant marketing strategy can help healthcare practices rise effectively.
In recent years, there has been an increased focus on real world evidence to advance medicalscience and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].
She graduated from the University of Toronto in 2013, and completed her PhD in Microbiology and Immunology at McGill University in 2017. Impetus Digital is the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. About Impetus Digital. Book a Consultative Demo.
When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. Regional Account Manager, and Shaun Terry, Sr.
The first human trial done in Israel proved very successful (2017-2018, finalized during COVID), and published in the Red Journal , the official journal of the American Society for Radiation Oncology), involving many patients whose cancer recurred after treatment or whose options were exhausted.
According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU. As a result, healthcare providers need to rely on generic manufacturers, but there are only a few who make them, he explains. Here, the long-term shortages can be attributed to two factors, says Page.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content